HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro activity of polyoxin D and nikkomycin Z against Encephalitozoon cuniculi.

Abstract
Microsporidia of the genus Encephalitozoon are emerging protozoal agents that mainly infect immunocompromised patients with AIDS. At present, disseminated infections with members of the genus Encephalitozoon can only be successfully treated with albendazole. As chitin is a basic component of the microsporidian spore. we evaluated, in vitro, the susceptibility of a human-derived strain of Encephalitozoon cuniculi to polyoxin D and nikkomycin Z, which are known competitive inhibitors of chitin synthetase enzymes. Using an in vitro assay, polyoxin D at 1, 10 and 100 microg/ml significantly reduced the number of parasitic foci on days 6, 9, and 15 post-infection. However, nikkomycin Z revealed a marked but lower reduction in the number of parasitic foci than polyoxin D. A significant reduction of parasitic foci was achieved for nikkomycin Z at 10 and 100 microg/ml up to day 9 post-infection. Polyoxin D was approximately tenfold more effective in our in vitro assay than nikkomycin Z.
AuthorsIngo Sobottka, Katrin Bartscht, Peter Schäfer, Thomas Weitzel, Justus Schottelius, Nico Kock, Rainer Laufs
JournalParasitology research (Parasitol Res) Vol. 88 Issue 5 Pg. 451-3 (May 2002) ISSN: 0932-0113 [Print] Germany
PMID12049463 (Publication Type: Journal Article)
Chemical References
  • Aminoglycosides
  • Anti-Bacterial Agents
  • Antiprotozoal Agents
  • Enzyme Inhibitors
  • Pyrimidine Nucleosides
  • nikkomycin
  • polyoxorim
  • Chitin Synthase
Topics
  • Aminoglycosides
  • Animals
  • Anti-Bacterial Agents (pharmacology)
  • Antiprotozoal Agents (pharmacology)
  • Chitin Synthase (antagonists & inhibitors)
  • Encephalitozoon cuniculi (drug effects, physiology)
  • Enzyme Inhibitors (pharmacology)
  • Humans
  • Parasitic Sensitivity Tests
  • Pyrimidine Nucleosides (pharmacology)
  • Spores, Protozoan (drug effects, enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: